London & Capital Asset Management Ltd Invests $1.05 Million in Smith & Nephew plc (NYSE:SNN)

London & Capital Asset Management Ltd bought a new stake in shares of Smith & Nephew plc (NYSE:SNN - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 38,622 shares of the medical equipment provider's stock, valued at approximately $1,054,000.

Several other hedge funds have also bought and sold shares of the business. Highland Capital Management LLC boosted its stake in Smith & Nephew by 1.8% during the fourth quarter. Highland Capital Management LLC now owns 24,915 shares of the medical equipment provider's stock worth $680,000 after acquiring an additional 450 shares in the last quarter. Boston Common Asset Management LLC raised its holdings in Smith & Nephew by 5.9% in the first quarter. Boston Common Asset Management LLC now owns 8,877 shares of the medical equipment provider's stock worth $248,000 after buying an additional 497 shares during the last quarter. Legacy Wealth Asset Management LLC raised its holdings in Smith & Nephew by 3.8% in the third quarter. Legacy Wealth Asset Management LLC now owns 15,026 shares of the medical equipment provider's stock worth $372,000 after buying an additional 546 shares during the last quarter. Bleakley Financial Group LLC raised its holdings in Smith & Nephew by 8.2% in the first quarter. Bleakley Financial Group LLC now owns 8,353 shares of the medical equipment provider's stock worth $233,000 after buying an additional 636 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in Smith & Nephew by 3.7% in the first quarter. Bank of New York Mellon Corp now owns 20,413 shares of the medical equipment provider's stock worth $570,000 after buying an additional 722 shares during the last quarter. Institutional investors own 25.64% of the company's stock.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of Smith & Nephew from a "buy" rating to a "strong-buy" rating in a report on Friday, March 15th. Three investment analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy".

Smith & Nephew Stock Up 0.1 %

SNN stock traded up $0.03 during midday trading on Monday, reaching $23.80. 916,744 shares of the company's stock traded hands, compared to its average volume of 959,283. Smith & Nephew plc has a 52-week low of $21.52 and a 52-week high of $33.08. The stock's 50-day moving average is $26.75 and its 200 day moving average is $25.99. The company has a quick ratio of 0.72, a current ratio of 1.77 and a debt-to-equity ratio of 0.44.

Smith & Nephew Announces Dividend

The company also recently announced a semi-annual dividend, which will be paid on Wednesday, May 22nd. Stockholders of record on Tuesday, April 2nd will be paid a $0.462 dividend. This represents a dividend yield of 2.8%. The ex-dividend date of this dividend is Monday, April 1st.

Smith & Nephew Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.